Grossi Federico

Chief Medical Officer | Chief Medical Officer | See Remarks

1 company

Average

Trades Analyzed

12M Win Rate

40.6%

Avg 3M Return

-8.5%

Avg 12M Return

-14.4%

Grossi Federico is a Chief Medical Officer at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.

Estimated insider holdings value: $3.9M based on current market prices.

Holdings by Company

APLSJan 5, 2023

Current Shares94.9K

Value$3.89M

Net Activity-45,956

Bought: 0Sold: 46.0K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 5, 2023	APLS Apellis Pharmaceuticals, Inc.	Chief Medical Officer	Sell	2,500	$48.79	$121,975.00	-2.6%	+62.6%	+25.3%
Dec 1, 2022	APLS Apellis Pharmaceuticals, Inc.	Chief Medical Officer	Sell	2,500	$49.93	$124,825.00	-2.5%	+28.5%	+23.7%
Nov 1, 2022	APLS Apellis Pharmaceuticals, Inc.	Chief Medical Officer	Sell	2,500	$60.83	$152,075.00	-2.4%	-13.1%	-17.7%
Oct 3, 2022	APLS Apellis Pharmaceuticals, Inc.	Chief Medical Officer	Sell	2,500	$66.69	$166,725.00	-2.4%	-17.6%	-36.2%
Sep 1, 2022	APLS Apellis Pharmaceuticals, Inc.	Chief Medical Officer	Sell	2,500	$60.30	$150,750.00	-2.3%	-21.5%	-31.6%
Aug 1, 2022	APLS Apellis Pharmaceuticals, Inc.	Chief Medical Officer	Sell	2,500	$55.99	$139,975.00	-2.3%	+8.5%	-56.6%
Jun 1, 2022	APLS Apellis Pharmaceuticals, Inc.	Chief Medical Officer	Sell	2,500	$41.78	$104,450.00	-2.2%	+42.3%	+111.1%
May 2, 2022	APLS Apellis Pharmaceuticals, Inc.	Chief Medical Officer	Sell	2,500	$43.56	$108,900.00	-2.2%	+24.0%	+84.9%
Mar 15, 2022	APLS Apellis Pharmaceuticals, Inc.	Chief Medical Officer	Sale+OE	375	$39.57	$14,838.75	-0.3%	-1.7%	+63.6%
Mar 1, 2022	APLS Apellis Pharmaceuticals, Inc.	Chief Medical Officer	Sell	375	$43.53	$16,323.75	-0.3%	-7.4%	+43.0%